Home
Eventide Asset Management reported a 6.3% stake in Ovid Therapeutics OVID · 11,812,241 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 6.3%
- Last report
- 7.3% · filed 26/05/15
- Shares held
- 11,812,241 sh
- Class
- Common Stock, par value $0.001 per share
- Event date
- 26/06/30
- Filed
- 26/08/14
6.3% stake · −1.0pp from the last report
- Stake
- 6.3%
- Last report
- 7.3%
- Since last report
- −1.0pp
Ovid Therapeutics trades, last 26 weeks
What else happened in Ovid Therapeutics around then
Filed or reported within 30 days of the trade day · 05/31~07/30Eventide Asset Management's other 5% stake reports
- Eventide Asset Management
5% stakeImmix Biopharma
5% stakeImmix Biopharma
IMMX
5.6% stake
3,891,019 sh
5.6% stake
Filed 08/14
- Eventide Asset Management
5% stakeXometry
5% stakeXometry
XMTR
4% stake
2,151,845 sh
4% stake
Filed 08/14
- Eventide Asset Management
5% stakeOvid Therapeutics
5% stakeOvid Therapeutics
OVID
7.3% stake
12,773,577 sh
7.3% stake
Filed 05/15
- Eventide Asset Management
5% stakeBeta Bionics
5% stakeBeta Bionics
BBNX
13.4% stake
5,945,488 sh
13.4% stake
Filed 05/15
- Eventide Asset Management
5% stakeCollegium Pharmaceutical
5% stakeCollegium Pharmaceutical
COLL
4.5% stake
1,424,282 sh
4.5% stake
Filed 05/15
